尿靛甙测定对糖耐量减退患者的应用价值

目的 探讨尿靛甙监测对糖耐量减退患者的应用价值。方法 在2015年1～2月健康查体的人群中选出96例符合WHO糖耐量减退(IGT)诊断标准的患者,随机分成48例实验组患者和48例对照组患者,两组患者在年龄和性别构成上差异无统计学意义,均无其他疾病,且均未服用过控制血糖的药物。IGT患者实验组使用尿靛甙监测来建立个体化饮食营养指导,而对照组使用普通健康教育指导,两组分别于实验前和实验结束时检测尿靛甙、空腹血糖、2 h糖耐量浓度水平,并进行比较。结果 根据两组人群一年的跟踪回访和实验数据的收集发现,实验结束时IGT患者实验组的尿靛甙水平为(50.7±6.2 mg/L vs 78.5±7.9 mg/L),空腹血糖水平为(6.34±0.11 mmol/L vs 6.91±0.29 mmol/L),2 h糖耐量水平为(7.81±0.52 mmol/L vs9.57±1.13 mmol/L)低于对照组的水平,两组比较差异有统计学意义(t=2.0,2.60,3.06,P值均<0.05)。IGT患者实验组内比较,实验结束时尿靛甙水平为(50.7±6.2mg/L vs 78.3±8.1 mg/L),空腹血糖水平为(6.34±0.11 mmol/L vs 6.78±0.19 mmol/L),2h糖耐量水平为(7.81±0.52 mmol/L vs 9.33±0.93 mmol/L)明显低于实验开始前的水平,差异有统计学意义(t=2.01,2.28,2.83,P值均<0.05)。在糖尿病各阶段的转归方面,IGT患者实验组明显优于对照组,差异有统计学意义(χ²=10.85,P<0.05)。结论 通过尿靛甙测定来指导糖耐量减退患者合理饮食,有利于糖耐量减退患者对血糖的控制,能有效减缓糖耐量减退(IGT)向糖尿病(DM)的转化,转变向积极的方向发展。

Application Value of Uric Indicant Monitoring on Patients with Impaired Glucose Tolerance

Objective To explore the application value of uric indicant monitoring on patients with impaired glucose tolerance.Methods 96 health examination people were selected who with glucosetolerance impairment diagnosis standard population in Jan to Feb 2015 in LaiZhou,There were no significant differences in age and sex composition between the two groups in 48 cases of experimental group and 48 cases in control group.Therewere no other diseases,and no drugs were taken to control blood glucose.IGTpatients in the experimental group using uric indican monitoring to establish personal diet guide,while the control group used normal health education guidance,the two groups respectively before experiment and at the end of detecting urinary indican,fasting blood glucose,2h glucose tolerance levels,and were compared.Results According to the findings of the two groups follow up and the experimental data collected during one year,at the end of theexperiment the IGT patients in the experimental group levels of urinary indicantwas(50.7±6.2 mg/L vs 78.5±7.9 mg/L),fasting blood glucose was(6.34±0.11 mmol/L vs 6.91±0.29 mmol/L),2h glucose tolerance was(7.81 ± 0.52 mmol/L vs 9.57 ±1.13 mmol/L)which was lower than the control group.There was significant difference between two groups(t=2.0,2.6,3.06,P<0.05).Compared with IGT in the experimental group at the end of the experiment,the level of uric indican was(50.7±6.2 mg/L vs 78.3±8.1 mg/L),fasting glucosewas(6.34±0.11 mmol/L vs 6.78±0.19 mmol/L),2h glucose tolerance was(7.81±0.52 mmol/L vs 9.33±0.93 mmol/L)was lower than before the start of thelevel(t=2.01,2.28,2.83,P<0.05),and the difference was statisticallysignificant.In terms of theoutcome of the various stages of diabetes,IGT patients in the experimental group was significantly better than the control group(χ²=10.85,P<0.05),the difference was statistically significant.Conclusion Through the determination of uric indican to guide the glucose tolerance decreasein patients with a reasonable diet,is conducive to glucose tolerance in the patients with impaired on blood glucose control,can effectively reduce the glucose tolerance decrease(IGT)conversion to diabetes mellitus(DM),change to a positive direction.